![Oliver Baumann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Oliver R.
Baumann is Chief Executive Officer & Director at Xlife Sciences AG since 2020, Chief Executive Officer at Akira Trading GmbH, Chairman at Akira Holding AG, Chairman & General Manager at Veraxa Biotech Holding AG, Director at Pecunia Solutions AG, Director at VERAXA Biotech AG, Director at Axenoll Life Sciences AG, and Co-Managing Director at Xrna.
Biotech GmbH.
Former roles include Chief Executive Officer at Belvoir Wealth Management AG and Co-Managing Director at x-diagnostics GmbH.
| Unternehmen | Position | Beginn |
|---|---|---|
| XLIFE SCIENCES AG | Vorstandsvorsitzender | 01.07.2019 |
Pecunia Solutions AG | Direktor/Vorstandsmitglied | - |
Axenoll Life Sciences AG | Direktor/Vorstandsmitglied | - |
Akira Holding AG | Vorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
Veraxa Biotech AG
 Veraxa Biotech AG BiotechnologyHealth Technology Develops antibodies based therapeutics | Direktor/Vorstandsmitglied | - |
Belvoir Wealth Management AG
 Belvoir Wealth Management AG Investment ManagersFinance Provides investment advice | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 6 |
|---|---|
Belvoir Wealth Management AG
Belvoir Wealth Management AG Investment ManagersFinance Provides investment advice | Finance |
Pecunia Solutions AG | |
Xlife Sciences AG
 Xlife Sciences AG Miscellaneous Commercial ServicesCommercial Services Develops life sciences technologies | Commercial Services |
Akira Holding AG | |
Veraxa Biotech AG
Veraxa Biotech AG BiotechnologyHealth Technology Develops antibodies based therapeutics | Health Technology |
Axenoll Life Sciences AG |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
